Skip to main content
Premium Trial:

Request an Annual Quote

Novartis Opens Tropical Disease Institute in Singapore Biopolis

NEW YORK, July 5 (GenomeWeb News) - Novartis opened a tropical diseases research facility today in Singapore's Biopolis, which will initially focus on drug-resistant tuberculosis and dengue fever.

 

The Novartis Institute for Tropical Diseases, a joint venture of the Swiss pharmaceutical giant and the Singapore Economic Development board, has the goal of getting at least two vaccines into the clinic by 2008, and onto the market by 2013, Novartis said. The center will be funded with $162.2 million over the next eight years, according to Novartis.  

 

The institute first began operations last year. Over 70 scientists and 30 students are slated to be working at the institute by the end of 2004.

 

The drug discovery activities at the Novartis institute will involve development of screening assays and target discovery. Biopolis also houses a DNA sequencing facility.

 

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.